Melinta Therapeutics

Therapeutics
Therapeutics
Current

Initial Transaction Details

Transaction Date
November 2017
Purpose of Financing
Growth
Stage of Company
Growth
Structure of Financing
Debt

Melinta Therapeutics is a biopharmaceutical company dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. The company focuses its expanding portfolio on serving patients with an unmet need to make the most meaningful impact.

Website